BIO-PROTOCOL · 2019 · 28 citations · 19 references
PharmacyMedicinal ChemistryPharmacologyBiopharmaceuticsDrug DiscoveryEnzymologyAssay DevelopmentCytotoxicity AssessmentCytotoxicity EvaluationNatural Product Drug DiscoveryAntimalarial Drug DevelopmentLeishmaniasis PathogenesisNatural Product PharmacologySelectivityTotal Phenolic Content
) and the selectivity index (SI) via the resazurin reduction assay. These protocols are based on the ability of resazurin (oxidized blue form) to be irreversibly reduced by enzymes in viable cells and generate a red fluorescent resorufin product and can be easily expanded to the investigation of the antimicrobial activity in other microorganisms.
19
S. Ansar Ahmed, Robert M. Gogal, Jane E. Walsh · Journal of Immunological Methods · 1994 · 1.4K citations